Chronic Myeloid Leukemia

Showing NaN - NaN of 31

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission, MDS Trial in Houston (CliniMACS)

Not yet recruiting
  • Acute Lymphoblastic Leukemia in Remission
  • +10 more
  • CliniMACS
  • Houston, Texas
  • +1 more
Dec 8, 2022

Myeloid Malignancies, Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Houston (Cyclophosphamide, Mesna, Filgrastim)

Recruiting
  • Myeloid Malignancies
  • +3 more
  • Houston, Texas
    M D Anderson Caner Center
Nov 17, 2022

Chronic Myeloid Leukemia Trial in Worldwide (ELVN-001)

Recruiting
  • Chronic Myeloid Leukemia
  • New York, New York
  • +22 more
Aug 15, 2022

Chronic Myeloid Leukemia, Chronic Myeloid Leukemia, BCR/ABL-Positive, in Remission, Chronic Myeloid Leukemia in Remission Trial

Recruiting
  • Chronic Myeloid Leukemia
  • +2 more
  • Imatinib Mesylate, Dasatinib, Nilotinib or Bosutinib Withdrawal
  • Imatinib Mesylate, Dasatinib, Nilotinib or Bosutinib Re-initiation
  • Houston, Texas
  • +3 more
Jan 25, 2022

Chronic Myelomonocytic Leukemia, Chronic Myeloid Leukemia, Polycythemia Vera Trial in Houston (Imatinib Mesylate (Gleevec))

Completed
  • Chronic Myelomonocytic Leukemia
  • +4 more
  • Imatinib Mesylate (Gleevec)
  • Houston, Texas
    UT MD Anderson Cancer Center
Dec 7, 2021

Chronic Myeloid Leukemia Trial in Worldwide (Omacetaxine mepesuccinate)

Completed
  • Chronic Myeloid Leukemia
  • Omacetaxine mepesuccinate
  • Los Angeles, California
  • +28 more
Dec 1, 2021

Chronic Myeloid Leukemia Trial in Worldwide (Omacetaxine mepesuccinate)

Completed
  • Chronic Myeloid Leukemia
  • Omacetaxine mepesuccinate
  • Los Angeles, California
  • +31 more
Nov 11, 2021

Chronic Myeloid Leukemia Trial in Worldwide (Omacetaxine mepesuccinate)

Terminated
  • Chronic Myeloid Leukemia
  • Omacetaxine mepesuccinate
  • Jacksonville, Florida
  • +9 more
Nov 6, 2021

Acute Myeloid Leukemia, Myelodysplastic Syndrome, Chronic Myeloid Leukemia Trial in Houston (Clofarabine, Busulfan, Fludarabine)

Completed
  • Acute Myeloid Leukemia
  • +2 more
  • Houston, Texas
    UT MD Anderson Cancer Center
Jan 6, 2021

Acute Myeloid Leukemia, Myelodysplastic Syndrome, Chronic Myeloid Leukemia Trial in Houston (Clofarabine 40mg/m^2, Idarubicin

Completed
  • Acute Myeloid Leukemia
  • +2 more
  • Clofarabine 40mg/m^2
  • +5 more
  • Houston, Texas
    UT MD Anderson Cancer Center
Dec 3, 2020

Leukemia, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia Trial in Houston (Fludarabine monophosphate, Busulfan, Stem Cell

Active, not recruiting
  • Leukemia
  • +9 more
  • Fludarabine monophosphate
  • +5 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Oct 2, 2020

Chronic Myeloid Leukemia Trial in Worldwide (Dasatinib, Nivolumab)

Completed
  • Chronic Myeloid Leukemia
  • Atlanta, Georgia
  • +20 more
Mar 4, 2020

Chronic Myeloid Leukemia Trial in Worldwide (Bosutinib, imatinib)

Completed
  • Chronic Myeloid Leukemia
  • Anaheim, California
  • +165 more
Dec 19, 2018

Chronic Myeloid Leukemia (CML) in a Real-world Setting

Unknown status
  • Chronic Myeloid Leukemia
  • Non-Interventional
  • Muscle Shoals, Alabama
  • +213 more
Jan 19, 2018

Acute Myeloid Leukemia, Chronic Myeloid Leukemia Trial in United States (PRI-724)

Completed
  • Acute Myeloid Leukemia
  • Chronic Myeloid Leukemia
  • Atlanta, Georgia
  • +5 more
Aug 16, 2017

Chronic Myeloid Leukemia Trial in Worldwide (Bosutinib)

Completed
  • Chronic Myeloid Leukemia
  • Duarte, California
  • +110 more
Jun 28, 2017

Acute Myelocytic Leukemia, Acute Lymphocytic Leukemia, Myeloproliferative Disease Trial in Houston (rigosertib)

Completed
  • Acute Myelocytic Leukemia
  • +3 more
  • Houston, Texas
    University of Texas M. D. Anderson Cancer Center
Jun 22, 2017

Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myeloid Leukemia Trial in Birmingham, Houston (AT9283)

Terminated
  • Acute Myeloid Leukemia
  • +4 more
  • Birmingham, Alabama
  • +1 more
Jan 8, 2016

Chronic Myeloid Leukemia Trial in Houston (Placebo, Armodafinil)

Terminated
  • Chronic Myeloid Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Nov 4, 2015

Chronic Myeloid Leukemia Trial in Houston (Peg Interferon Alpha 2b (Peg Intron), Ara-C (cytosine arabinoside))

Completed
  • Chronic Myeloid Leukemia
  • Peg Interferon Alpha 2b (Peg Intron)
  • Ara-C (cytosine arabinoside)
  • Houston, Texas
    The University of Texas M.D. Anderson Cancer Center
Nov 25, 2015

Chronic Myeloid Leukemia, Leukemia, Lymphoblastic, Acute, Philadelphia-Positive Trial in United States (XL228)

Terminated
  • Chronic Myeloid Leukemia
  • Leukemia, Lymphoblastic, Acute, Philadelphia-Positive
  • Los Angeles, California
  • +5 more
Aug 19, 2015

Chronic Myeloid Leukemia Trial in Worldwide (ponatinib, imatinib (Gleevec/ Glivec))

Terminated
  • Chronic Myeloid Leukemia
  • Burbank, California
  • +169 more
Nov 5, 2014

Chronic Myeloid Leukemia Trial in United States (DCC-2036)

Completed
  • Chronic Myeloid Leukemia
  • Duarte, California
  • +9 more
Jul 16, 2014

Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphoblastic Leukemia Trial in Houston (Bendamustine)

Terminated
  • Acute Myeloid Leukemia
  • +3 more
  • Houston, Texas
    UT MD Anderson Cancer Center
Dec 3, 2012

Chronic Myeloid Leukemia, Minimal Residual Disease Trial in Houston (Synthetic Tumor-Specific Breakpoint Peptide Vaccine)

Completed
  • Chronic Myeloid Leukemia
  • Minimal Residual Disease
  • Synthetic Tumor-Specific Breakpoint Peptide Vaccine
  • Houston, Texas
    UT MD Anderson Cancer Center
Aug 1, 2012